Palmicol

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Palmicol

Quick Facts Description
Active Ingredient Chloramphenicol
Form Ophthalmic Solution / Ointment
Pharmacological Class Broad-Spectrum Antibiotic
General Purpose Controlling bacterial growth
Origin Synthetic

Defining Palmicol: Classification and Active Component

Palmicol is a prescription-only medicine that is classified pharmacologically as an antibiotic and a potent antimicrobial agent. Its sole active ingredient, Chloramphenicol, is a broad-spectrum antibiotic that is clinically recognized for its efficacy against a wide range of bacterial pathogens. This medication is a synthetic compound, chemically produced to yield the therapeutically active D-threo stereoisomer. Chloramphenicol is recognized as a drug used in the treatment of certain susceptible bacterial infections. This established characteristic allows Palmicol to effectively target the common pathogens responsible for external ocular issues.

The Topical Form: Ophthalmic Solution and Ointment

Palmicol is prepared exclusively for topical ophthalmic use, administered directly to the eye as an ophthalmic solution (eye drops) or an ophthalmic ointment. The specific preparation of Palmicol as a localized, non-systemic treatment is a differentiating factor, emphasizing delivery to the eye surface. The ophthalmic solution uses an aqueous base for rapid application, while the ophthalmic ointment incorporates a lipophilic base for prolonged contact time on the ocular surface. This tailored approach allows healthcare providers to match the delivery form to the patient's specific need, ensuring the antimicrobial agent is present where required.

Palmicol's General Purpose: Controlling Bacterial Growth

The fundamental purpose of Palmicol is to stop the progression of external bacterial infections of the eye by inhibiting the ability of pathogens to multiply. The active component, Chloramphenicol, functions primarily as a bacteriostatic agent. By binding to the 50S ribosomal subunit, the drug prevents bacteria from producing the necessary proteins required for growth and division. This mechanism of inhibition of bacterial protein synthesis effectively arrests the infection's spread, allowing the body's natural immune mechanisms to successfully eliminate the suppressed bacterial population.

What side effects are possible with Palmicol?

Possible Side Effects and Safety Information

Palmicol, which contains Chloramphenicol, is associated with documented adverse reactions and specific regulatory constraints. This information is based strictly on official government regulatory documents, detailing the drug's safety profile.


Documented Adverse Reactions by System

System-Organ Class Common/Local Reactions Serious/Rare Reactions
Eye Disorders Transient irritation, burning, stinging, itching, dermatitis, transient blurring of vision. Not applicable
Immune System Hypersensitivity reactions (including angioedema, urticaria, fever). Not applicable
Blood and Lymphatic System Not applicable Aplastic Anaemia (rare, potentially fatal risk), Bone Marrow Hypoplasia/Depression.

Safety Considerations and Contraindications

The regulatory label includes specific constraints regarding the use of Palmicol, particularly concerning exposure and high-risk populations:

  • Contraindications: Palmicol is officially contraindicated in individuals with a known personal or family history of blood dyscrasias, including aplastic anaemia, or previous myelosuppression from chloramphenicol.
  • Pregnancy and Lactation: Use is not recommended during pregnancy or while breastfeeding due to the potential for systemic absorption.
  • Exposure-Related Risk: The most serious risks, including Aplastic Anaemia, are reported to be associated with prolonged or frequent intermittent use. For this reason, the duration of use is typically limited.
  • Restrictions: Contact lenses must be removed during treatment. Concomitant use with other medications that may suppress bone marrow function should be avoided.

Overdose and Emergency Response

Overdose and When to Seek Help

Palmicol is the palmitate form of chloramphenicol, an antibiotic historically associated with significant toxicity, particularly following high doses or systemic exposure.

Overdose or toxicity from chloramphenicol can be evidenced by serious hemopoietic effects (blood disorders) such as aplastic anemia, hypoplastic anemia, thrombocytopenia, and leukopenia. Excessive blood levels, often considered to be above 25 µg/mL, are frequently associated with toxicity, which may also include symptoms like nausea, vomiting, and diarrhea.

Population-Specific Overdose Risk

Infants, especially preterm and newborn neonates, are at particular risk for a severe, life-threatening overdose syndrome known as Gray Syndrome (or Gray Baby Syndrome). This condition is caused by the infant's inability to metabolize and excrete the drug, leading to accumulation in the body. Symptoms appear in a rapid progression, including abdominal distension, vomiting, progressive pallid cyanosis (gray skin color), vasomotor collapse, irregular respiration, and often death within hours.

Emergency Response

Immediate medical help is required in any case of suspected overdose or if the signs of toxicity, such as those described above, appear. Contact a healthcare professional, hospital emergency department, or a regional Poison Control Center immediately, even if no symptoms are present. High-level systemic exposure may be managed through procedures such as charcoal hemoperfusion to help remove the drug from plasma.

Therapeutic Uses of Palmicol

What Palmicol treats: main uses and benefits

Palmicol is commonly used to help with acute bacterial eye infections and related symptoms that create noticeable physiological strain on the ocular surface. The application of the medicine is considered relevant for the management of bacterial conjunctivitis in adults and children. It is also used in conditions involving superficial bacterial keratitis and acute blepharitis exacerbations.

The medication is applied in addressing symptom clusters that may become noticeable, such as pronounced redness, a gritty sensation, and significant mucopurulent discharge associated with the condition.

“Palmicol supports the management of bacterial proliferation and assists with maintaining functional stability when symptoms interfere with routine activities.”

In specific clinical scenarios, it may be part of symptomatic management to provide supportive relief after minor eye trauma or procedures, where short-term symptomatic assistance is needed. It contributes to easing the overall symptom load and may help patients cope more steadily with symptom fluctuations.

Quick Fact Relief for Symptomatic Discomfort
Primary Focus Acute bacterial eye infections
Key Symptoms Addressed Ocular redness, discharge, grittiness
Benefit Supports the patient during difficult episodes by easing distress

Eligibility and Restrictions for Use

Who can and cannot use Palmicol?

This section defines eligibility for Palmicol (Chloramphenicol Ophthalmic) strictly according to official regulatory labeling, outlining required use and absolute prohibitions.

Eligibility Status (Official Label) Specific Populations
Approved for Use Adults; Older Adults; Children aged 2 years and over.
Conditional Use Children under 2 years (requires medical advice); Newborn infants (use with caution/dose adjustment).
Not Recommended Pregnant individuals; Breastfeeding individuals.
Contraindicated Individuals with known hypersensitivity to chloramphenicol or excipients; Patients with a personal or family history of blood dyscrasias (e.g., aplastic anaemia); Patients with prior myelosuppression from chloramphenicol exposure.

Age-Related Eligibility

The medicine is approved for general use in adults and children aged 2 years and over. Use in children under 2 years is not recommended without a doctor’s prescription. No dosage modification is typically indicated for older adults.

Key Eligibility Restrictions

Patients must not wear contact lenses during treatment. Eligibility is also conditional upon seeking medical advice for pre-existing eye conditions like glaucoma or dry eye syndrome.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Palmicol (Chloramphenicol Ophthalmic) is defined by pharmacokinetic and pharmacodynamic constraints arising from its systemic absorption. This framework outlines necessary restrictions and requirements for co-administration.


Documented Interaction Patterns

Category Regulatory Statement
Additive Toxic Risk Co-administration with drugs liable to depress bone marrow function is restricted due to a severe additive risk of bone marrow hypoplasia.
Metabolic Mechanism Palmicol is documented as an inhibitor of Cytochrome P450 enzymes (CYP2C19, CYP3A4), affecting the clearance of co-administered drugs.
Exposure Modification Inhibition of CYP enzymes leads to increased plasma concentrations of medicines like Oral Anticoagulants (e.g., Warfarin) and Anti-epileptics (e.g., Phenytoin).
Physical Separation Administration of Palmicol and other ophthalmic preparations requires minimum time separation to prevent the physical washout of the active ingredient.

Interaction-Related Restrictions

The most significant restriction is the mandate to avoid simultaneous use with other substances that may cause bone marrow depression. Furthermore, the risk of systemic side effects is officially documented as heightened in patient populations with Hepatic Impairment, requiring special consideration due to slower metabolic clearance. This regulatory structure establishes a clear boundary for safe co-administration, focusing on preventing critical toxic and pharmacokinetic effects.

Mechanism of Action

Inhibition of Microbial Protein Synthesis

Palmicol's active component, Chloramphenicol, works by binding reversibly to the 50S ribosomal subunit of susceptible bacteria at the Peptidyl Transferase Center (PTase). This binding competitively inhibits the enzyme responsible for creating peptide bonds, thereby blocking the essential process of protein synthesis and the subsequent ability of the bacterial cell to generate the structural and functional components needed for survival and division.

The Bacteriostatic Physiological Effect

By halting protein synthesis, the drug functionally stops the growth and multiplication of the bacterial population, classifying its action as bacteriostatic. This arrest of microbial growth limits the progression of the pathogen population, leading to a non-replicating population that allows endogenous clearance processes to proceed.

Constraints on Mechanism Efficacy

The efficacy of the action is constrained by bacterial defense mechanisms, primarily the production of the Chloramphenicol Acetyltransferase (CAT) enzyme, which chemically inactivates the drug before it can reach the ribosome. Furthermore, certain bacteria can utilize efflux pumps to actively expel the drug from the cell. These counter-mechanisms prevent effective ribosomal binding, which explains why the mechanism may be overridden, resulting in sustained microbial replication.

Dosage and Administration Information

Official Administration Guidelines for Palmicol

Palmicol (Chloramphenicol) is administered via several approved routes, depending on the dosage form and the nature of the infection. Systemic treatment requires precise dosing based on body weight, while topical forms have specific application schedules.


Systemic Dosing and Frequency

Patient Group Standard Daily Dose Frequency
Adults and Children (> 2 weeks) 50 mg/kg/day Divided doses, typically every 6 hours (Q6H)
Neonates (< 2 weeks) 25 mg/kg/day Divided doses, typically every 6 hours (Q6H)
  • Dosing Adjustments: For severe, life-threatening infections, doses up to 100 mg/kg/day may be used temporarily, but must be reduced to 50 mg/kg/day as soon as clinically possible. Dosage must be reduced in patients with impaired hepatic function.

Route-Specific Instructions

  • Oral Administration: Capsules should generally be taken on an empty stomach (1 hour before or 2 hours after meals) for optimal absorption.
  • Intravenous (IV) Use: The powder for injection must be reconstituted and administered by slow intravenous infusion or slow IV injection (over at least one minute) to ensure proper plasma levels and minimize potential local reactions.
  • Topical Ocular Use: Drops are applied to the affected eye(s) and may require dosing as frequently as every 2 hours for the first 48 hours. The total duration of topical therapy should not exceed 5 to 7 days.

Course Duration and Missed Doses

Treatment duration for systemic infections, such as typhoid fever, typically continues for 8 to 10 days or for a specified number of days after the patient becomes afebrile. If a dose is missed, take it as soon as remembered; however, do not double the dose to make up for a missed one, but resume the regular dosing schedule.

Recent Clinical Evidence

Palmicol is an alternate trade name for Chloramphenicol, a broad-spectrum antibiotic. Clinical evidence focuses on its effectiveness in treating a variety of serious bacterial infections, particularly when other antibiotics are ineffective or contraindicated.


Primary Clinical Applications

Palmicol (Chloramphenicol) has a well-established history and is primarily reserved for conditions where its potent, bacteriostatic action against both Gram-positive and Gram-negative bacteria is critical. It functions by inhibiting bacterial protein synthesis via binding to the 50S ribosomal subunit.

The clinical applications where Palmicol is most commonly used or remains a standard option include:

  • Topical Ocular and Otic Infections: It is a common treatment for superficial eye infections, such as bacterial conjunctivitis, and otitis externa (outer ear infection), due to its efficacy against typical causative organisms like Staphylococcus aureus and Streptococcus pneumoniae.
  • Systemic Infections: Due to the risk of severe side effects, systemic use is restricted to serious, life-threatening infections where the benefits outweigh the risks. These can include typhoid fever caused by Salmonella typhi, rickettsial diseases, and certain types of bacterial meningitis in patients who cannot receive alternative treatments.

Safety and Monitoring

Recent clinical data emphasizes the need for careful monitoring due to the risk of significant adverse effects, particularly bone marrow suppression, which can lead to the rare but potentially fatal condition of aplastic anemia. This risk is predominantly associated with systemic (oral or intravenous) administration, though it may occur rarely with topical use due to systemic absorption.

Guidelines strongly recommend therapeutic drug monitoring in vulnerable populations, such as neonates and patients with impaired liver or kidney function, to maintain drug levels within the therapeutic window and minimize toxicity. The use of Palmicol in neonates is associated with a risk of "Gray Baby Syndrome."

Clinical Area Typical Administration Key Finding
Bacterial Conjunctivitis Topical (Eye drops/Ointment) High local efficacy against susceptible strains.
Typhoid Fever Oral/Intravenous Reserved for severe, multidrug-resistant cases.
Meningitis Intravenous Effective penetration into the central nervous system.

Despite rising concerns over antibiotic resistance and the development of newer agents, Palmicol remains a clinically important option for specific severe infections, especially in regions with high resistance rates to common antibiotics.

Frequently Asked Questions (FAQ)

Common questions about Palmicol (FAQ)


Q: Can Palmicol be taken with over-the-counter pain relievers like ibuprofen?

According to official product information, Palmicol is known to inhibit certain liver enzymes called Cytochrome P450 (CYP) enzymes. These enzymes are responsible for processing many other medicines in the body. If Palmicol affects this processing, the levels of co-administered drugs, which may include some common pain relievers, could potentially increase. It is important to discuss all over-the-counter medications used with a healthcare professional.


Q: Can people with kidney issues use Palmicol safely?

Regulatory documents state that caution is necessary when Palmicol is used by patients with significantly impaired kidney or liver function. There is a potential for the body to clear the drug slower than normal, which may lead to drug accumulation. For this reason, dosage adjustments or careful blood monitoring may be part of the required medical plan.


Q: Is Palmicol suitable for people with a history of anxiety or depression?

Official adverse reaction data includes reports of neurotoxic reactions associated with Palmicol, such as mild depression, mental confusion, and delirium. Patients with pre-existing conditions involving the central nervous system may be monitored closely during treatment due to the potential for these side effects.


Q: Has Palmicol been studied in pregnant or breastfeeding individuals?

There are no adequate and well-controlled studies on the use of Palmicol in human pregnancy, and it is generally categorized as a drug to be used only if clearly needed. The active ingredient in Palmicol is known to cross the placental barrier when administered systemically. Furthermore, it passes into breast milk and is generally avoided in breastfeeding individuals due to the potential for toxic effects on the infant.


Q: Are there any long-term side effects associated with Palmicol use?

The most serious blood-related issues, such as aplastic anemia, have been reported after both short-term and long-term use of Palmicol. Additionally, conditions like optic and peripheral neuritis, which affect the nerves, have also been reported, usually following prolonged courses of therapy. Due to these potential risks, the duration of use is generally limited, as noted in the product labeling.


Q: Does Palmicol cause drowsiness or make you tired?

Official adverse reaction lists mention drowsiness as a rare side effect associated with Palmicol use. Feelings of unusual tiredness or weakness have also been reported. These symptoms may warrant discussion with a healthcare provider.


Q: Is it normal to feel a slight headache when first starting Palmicol?

According to the official product monograph, headache is listed as one of the less common side effects reported when taking systemic Palmicol. Persistent or severe headaches should be discussed with a healthcare provider.


Q: What happens if I accidentally miss a dose of Palmicol?

For topical products like eye drops or ointment, official patient instructions recommend that if a dose is missed, it should be applied as soon as it is remembered. After that, the regular application schedule should be resumed. Following the prescribed schedule is important for maintaining the drug’s effectiveness.


Q: How long does Palmicol stay in your system after stopping it?

Systemic Palmicol is cleared from the body relatively quickly. Regulatory pharmacokinetics data indicates that the drug has an elimination half-life that ranges from approximately 1.5 to 4.1 hours in adults with normal liver function. This half-life is an indicator of how quickly the body processes and removes the drug.


Q: Does Palmicol interact with common blood pressure medications?

Yes, Palmicol can interact with certain blood pressure medications, such as calcium channel blockers. Because Palmicol inhibits certain liver enzymes, it may lead to increased blood levels of these co-administered drugs. This interaction may increase the risk of side effects like low blood pressure, which is why monitoring may be part of the treatment plan.


Q: How common are skin-related side effects with Palmicol?

The official adverse reaction data reports that hypersensitivity reactions, which can include skin rashes, are a potential side effect. Other skin conditions noted in the product monograph include macular and vesicular rashes. Any suspected allergic reaction or severe rash should be brought to the attention of a healthcare professional.


Q: Is Palmicol a relatively new drug or has it been around for a while?

The active ingredient in Palmicol, Chloramphenicol, is considered an older antibiotic. It was originally discovered in the 1940s and holds historical significance as the first broad-spectrum antibiotic to be produced entirely by chemical synthesis.


Q: Does taking Palmicol require regular blood tests?

Yes, if systemic Palmicol is prescribed, the official labeling mandates close monitoring of blood health. Baseline blood studies are typically required, followed by periodic blood studies approximately every two days throughout the course of therapy. Monitoring is typically required to detect any adverse changes in blood counts in a timely manner.


Q: Can Palmicol cause stomach upset?

Gastrointestinal issues are reported as potential adverse reactions to Palmicol. These include a low incidence of nausea, vomiting, and diarrhea. Persistent stomach upset while using this medication should be discussed with a healthcare professional.


Q: What are the most serious, though rare, side effects of Palmicol?

The official label includes a Boxed Warning highlighting the risk of serious and potentially fatal blood problems, most notably aplastic anemia. Another serious, though rare, reaction is 'Gray Syndrome,' a dangerous condition that occurs primarily in premature and newborn infants, characterized by abdominal distension and an ashen color.


Q: Why might a doctor prescribe a lower dose of Palmicol for some patients?

A lower than standard dose may be part of the medical plan for certain patients to prevent the drug from building up to high levels in the body. This includes individuals with impaired liver or kidney function, as well as neonates and infants, who require lower, weight-based dosing due to differences in how their bodies process the medication.

How should Palmicol be stored and disposed of?

The storage and disposal of Palmicol (Chloramphenicol Ophthalmic Solution/Ointment) must comply with official regulatory labeling to maintain stability and prevent environmental harm.

Storage Requirements

Condition Ophthalmic Solution Ophthalmic Ointment
Temperature Refrigerate (2 C to 8 C) before opening; do not freeze Store below 25 C or 30 C
Protection Keep in original container, protected from light and heat.
In-Use Stability Must be discarded 28 days after first opening, regardless of remaining quantity.
Child Safety Keep strictly out of the sight and reach of children.

Disposal

Unused or expired Palmicol must not be disposed of via wastewater (flushed down the drain) or placed into general household waste. The product must be returned to a pharmacist or a designated drug take-back program for proper disposal, in accordance with local environmental regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Palmicol found in:

A-Z Index: